The top-line results of the APOLLOE4 trial showed that valitramiprosate (ALZ-801) was unable to slow down cognitive decline ...

Since 1938, animal testing has been required by the FDA before any new drug can proceed through clinical trials and receive ...

Following the success of the Boston and European editions, the ESG in Life Sciences Summit West is bringing together senior ...

Successful execution of established brand strategies requires developing specific operational capabilities. This includes developing efficient shared services, streamlined compliance processes, and ...

AKT inhibitor Truqap (capivasertib) has been cleared by NICE for use in combination with standard therapy fulvestrant for HR-positive, HER2-negative metastatic breast cancer that also has one or more ...

Incyte's infringement lawsuit is claiming that Sun Pharma's drug infringes a US patent (No. 9,662,335) it holds on the use of ...

EVERSANA has added another feature to its ORCHESTRATE platform for the commercialisation of life science products – an ...

The oral drug – Johnson & Johnson's Balversa (erdafitinib) – will become an option for adults with metastatic or unresectable ...

For Reuters Pharma Europe 2025, pharmaphorum is providing coverage courtesy NAVLIN Daily, a pricing and market access ...

Soliris contributed $2.58 billion in global revenues to AZ last year, a 14% drop on the prior year, of which just over $1.4 ...

A notice posted by the NIH in February said the agency would slash its funding of indirect costs borne by research teams at ...